Quantifying the Ligand-Coated Nanoparticle Delivery to Cancer Cells in Solid Tumors

ACS Nano
Qin DaiWarren C W Chan

Abstract

Coating the nanoparticle surface with cancer cell recognizing ligands is expected to facilitate specific delivery of nanoparticles to diseased cells in vivo. While this targeting strategy is appealing, no nanoparticle-based active targeting formulation for solid tumor treatment had made it past phase III clinical trials. Here, we quantified the cancer cell-targeting efficiencies of Trastuzumab (Herceptin) and folic acid coated gold and silica nanoparticles in multiple mouse tumor models. Surprisingly, we showed that less than 14 out of 1 million (0.0014% injected dose) intravenously administrated nanoparticles were delivered to targeted cancer cells, and that only 2 out of 100 cancer cells interacted with the nanoparticles. The majority of the intratumoral nanoparticles were either trapped in the extracellular matrix or taken up by perivascular tumor associated macrophages. The low cancer cell targeting efficiency and significant uptake by noncancer cells suggest the need to re-evaluate the active targeting process and therapeutic mechanisms using quantitative methods. This will be important for developing strategies to deliver emerging therapeutics such as genome editing, nucleic acid therapy, and immunotherapy for cancer trea...Continue Reading

References

Apr 17, 2003·Journal of the American Chemical Society·Alexander G TkachenkoDaniel L Feldheim
Apr 12, 2006·Proceedings of the National Academy of Sciences of the United States of America·Omid C FarokhzadRobert Langer
Apr 13, 2006·Nano Letters·B Devika ChithraniWarren C W Chan
Jul 25, 2006·Nature Reviews. Cancer·Andrew I Minchinton, Ian F Tannock
Jul 26, 2008·Nature Nanotechnology·Wen JiangWarren C W Chan
Aug 30, 2008·Trends in Biotechnology·Kathleen F Pirollo, Esther H Chang
Apr 7, 2009·Nano Letters·Steven D PerraultWarren C W Chan
Jan 19, 2010·Proceedings of the National Academy of Sciences of the United States of America·Chung Hang J ChoiMark E Davis
Sep 15, 2010·Nature Reviews. Clinical Oncology·Rakesh K Jain, Triantafyllos Stylianopoulos
Jan 20, 2011·Proceedings of the National Academy of Sciences of the United States of America·Cliff WongDai Fukumura
Jun 15, 2011·Journal of Controlled Release : Official Journal of the Controlled Release Society·You Han Bae, Kinam Park
Sep 29, 2011·Journal of Controlled Release : Official Journal of the Controlled Release Society·Twan LammersGert Storm
Mar 23, 2012·Nature Reviews. Cancer·Andrew M ScottLloyd J Old
Oct 24, 2013·Nature Materials·Vikash P Chauhan, Rakesh K Jain
Oct 9, 2014·Angewandte Chemie·Tianmeng SunYounan Xia
Oct 16, 2014·Proceedings of the National Academy of Sciences of the United States of America·Li TangJianjun Cheng
Jun 20, 2015·Chemical Reviews·Yuanzeng MinAndrew Z Wang
Aug 19, 2015·Nanomedicine : Nanotechnology, Biology, and Medicine·Triantafyllos Stylianopoulos, Rakesh K Jain
Oct 28, 2015·Nature Communications·Miles A MillerRalph Weissleder
Nov 20, 2015·Science Translational Medicine·Miles A MillerRalph Weissleder
Feb 18, 2016·Proceedings of the National Academy of Sciences of the United States of America·Edward A SykesWarren C W Chan
Sep 2, 2016·Molecular Cancer Therapeutics·Leon P PradelCarola H Ries
Nov 12, 2016·Nature Reviews. Cancer·Jinjun ShiOmid C Farokhzad

❮ Previous
Next ❯

Citations

Nov 13, 2018·Expert Opinion on Drug Delivery·Sofie SnipstadTwan Lammers
Mar 29, 2019·Journal of Biomedical Materials Research. Part a·Danielle M ValcourtEmily S Day
Apr 9, 2019·Expert Opinion on Drug Delivery·Stefania BiffiPaola Secchiero
Jul 10, 2019·Proceedings of the National Academy of Sciences of the United States of America·Benjamin R KingstonWarren C W Chan
Sep 4, 2019·Nature Nanotechnology·Colleen N LoynachanMolly M Stevens
Dec 5, 2019·Biomaterials Science·S BusattoP Bergese
Jan 15, 2020·Soft Matter·John R Clegg, Nicholas A Peppas
Mar 12, 2020·Therapeutic Delivery·Zhongjian ChenYi Lu
Sep 29, 2019·Advanced Materials·Meilyn SylvestreSuzie H Pun
Jan 15, 2020·Nature Materials·Shrey SindhwaniWarren C W Chan
May 21, 2020·Wiley Interdisciplinary Reviews. Nanomedicine and Nanobiotechnology·Manman XieHui Mao
Apr 3, 2019·Cancers·Meital Ben-David-NaimGershon Golomb
May 27, 2020·Journal of Materials Chemistry. B, Materials for Biology and Medicine·N'Dea S Irvin-ChoyEmily S Day
Sep 9, 2020·Nature Nanotechnology·Wilson PoonWarren C W Chan
Dec 24, 2019·Frontiers in Bioengineering and Biotechnology·Yuanyuan TianLianhui Wang
Jun 25, 2020·Journal of Materials Chemistry. B, Materials for Biology and Medicine·Jia-Xian LiJin-Zhi Du
Sep 11, 2020·Molecular Imaging and Biology : MIB : the Official Publication of the Academy of Molecular Imaging·Nicholas B SobolJason S Lewis
Feb 13, 2019·Beilstein Journal of Nanotechnology·Gonzalo Villaverde, Alejandro Baeza
Feb 19, 2019·Frontiers in Immunology·Bengt Fadeel
Mar 5, 2019·Biological & Pharmaceutical Bulletin·Yağız Anıl ÇiçekVincent M Rotello
Feb 10, 2019·Pharmaceutics·Parisa EslamiStefano Fedeli
Jan 11, 2020·Frontiers in Bioengineering and Biotechnology·Oliver S Thomas, Wilfried Weber
Feb 23, 2020·Macromolecular Bioscience·Sara Maslanka FigueroaAchim Goepferich
Apr 29, 2020·Nature Communications·Israel SantanaJuan Pablo Giraldo

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.